- €133.95m
- €189.52m
- €330.56m
- 79
- 37
- 42
- 51
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 275 | 246 | 248 | 274 | 331 |
Cost of Revenue | |||||
Gross Profit | 184 | 159 | 158 | 169 | 224 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 268 | 246 | 248 | 270 | 311 |
Operating Profit | 6.34 | 0.494 | -0.062 | 3.85 | 19.1 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 3.42 | -1.29 | -1.52 | 3.85 | 2.01 |
Provision for Income Taxes | |||||
Net Income After Taxes | 1.35 | -3.53 | -4.93 | 1.93 | 0.182 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 1.34 | -3.5 | -4.91 | 1.95 | 0.195 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 1.34 | -3.5 | -4.91 | 1.95 | 0.195 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.516 | -0.362 | -0.651 | 0.403 | 0.232 |
Dividends per Share |